Abstract 395P
Background
Google Trends, a free web-based tracking system of Google search volumes, can be used to monitor online interest in various health conditions, including lung cancer. This is particularly useful in the Philippines, the country named as the world's number one internet user in 2018. Understanding the pattern of information-seeking behavior of Filipinos with regards to lung cancer is crucial because it may inform public policy and potentially make lung cancer awareness campaigns more directed and effective in the population-based setting. Here we described patterns in online search behaviors related to lung cancer using Google Trends data on Google web and YouTube searches in the Philippines for the past ten years.
Methods
Relative search volumes on the term “lung cancer” from 2009 to 2019 were extracted from Google Trends. Both Google web search and YouTube search data were downloaded. The data were saved in a comma-separated values file then imported to Microsoft Excel where a graph was plotted and a polynomial trendline (second order) was added to estimate search trends over a time period. Regions and cities in the Philippines where the term “lung cancer” was most popular were identified. Related topics and queries were also enumerated.
Results
Trends in Google web search showed a steady interest in lung cancer for both Google web search and YouTube searches from 2009 to 2019, with peaks in 2014. No spikes were observed in August, the Philippines’ Lung Cancer Awareness month. Online search behaviour for lung cancer was greatest in Metro Manila and areas in Northern Philippines. Top related and rising topics and queries in lung cancer, both on Google web search and YouTube, were related to etiology, symptoms, and management of lung cancer.
Conclusions
Filipinos had a steady interest in lung cancer, as shown by Google Trends data for both Google web search and YouTube searches from 2009 to 2019. Cancer diagnoses of Filipino personalities in 2014 may have led to peaks in online interest. Filipinos were also interested to learn about etiology, symptoms, and management of lung cancer. These data may be used to leverage online interest to optimize lung cancer awareness campaigns in the Philippines.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
328P - A retrospective analysis of patients with non-small cell lung cancer who developed drug-induced lung disorder by immune checkpoint inhibitors
Presenter: Fumiko Hayashi
Session: Poster display session
Resources:
Abstract
329P - High-level expression of HDAC10 is associated with PD-L1 expression and poor prognosis in patients with non-small cell lung cancer receiving pulmonectomy
Presenter: Xiaomei Liu
Session: Poster display session
Resources:
Abstract
331P - A retrospective analysis of immune checkpoint therapy in patients with non-small cell lung cancer: Focus on thyroid disorder
Presenter: Sawana Ono
Session: Poster display session
Resources:
Abstract
332P - Analyse the association between adverse events (AEs) and survival in patients treated with immune checkpoint inhibitors (ICIs)
Presenter: Chi-yuan Cheng
Session: Poster display session
Resources:
Abstract
333P - Study of searching on efficacy of immune checkpoint inhibitor for the non-small cell lung cancer using FDG-PET/CT and thallium SPECT
Presenter: KAYOKO Kibata
Session: Poster display session
Resources:
Abstract
334P - Incidence and characteristic of adrenal insufficiency due to immune checkpoint inhibitors therapy
Presenter: Daisuke Etoh
Session: Poster display session
Resources:
Abstract
335P - PD-L1 profile of nasopharyngeal cancer patients in Indonesia
Presenter: Handoko Handoko
Session: Poster display session
Resources:
Abstract
336P - Pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for PD-L1-positive advanced non-small cell lung cancer in the real world
Presenter: Jun Sugisaka
Session: Poster display session
Resources:
Abstract
337P - Neutrophil-to-Lymphocyte ratio as a predictive factor for hyperprogressive disease in NSCLC patients treated with immune checkpoint inhibitor
Presenter: Ryo Takahashi
Session: Poster display session
Resources:
Abstract
338P - A new insight into tumour immune-evasion: Crosstalk between cancer stem cells and T regulatory cells
Presenter: Abhishek Dutta
Session: Poster display session
Resources:
Abstract